scholarly article | Q13442814 |
P2093 | author name string | Mortimer Poncz | |
Kandace Gollomp | |||
Michele P Lambert | |||
P2860 | cites work | Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin | Q47879370 |
Antithrombotic thrombocytes: ectopic expression of urokinase-type plasminogen activator in platelets | Q53934182 | ||
Dynamic Visualization of Thrombopoiesis Within Bone Marrow | Q58450371 | ||
Bacterial contamination in platelet concentrates | Q58802953 | ||
The effect of storage on the expression of platelet membrane phosphatidylserine and the subsequent impacton the coagulant function of stored platelets | Q73149076 | ||
Exposure of human megakaryocytes to high shear rates accelerates platelet production | Q84068352 | ||
Manipulation of oxygenation and flow-induced shear stress can increase the in vitro yield of platelets from cord blood | Q84857092 | ||
Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes | Q86657049 | ||
Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
Why has demand for platelet components increased? A review | Q28249969 | ||
A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis | Q30528487 | ||
Neonatal and adult megakaryopoiesis | Q33396149 | ||
Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells | Q33413336 | ||
Platelet transfusion: a clinical practice guideline from the AABB. | Q33418628 | ||
Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models. | Q33421373 | ||
The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors | Q33440323 | ||
FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology. | Q33441252 | ||
Towards the Manufacture of Megakaryocytes and Platelets for Clinical Application. | Q33442786 | ||
Platelet bioreactor-on-a-chip | Q34209300 | ||
Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional | Q34293080 | ||
Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies. | Q35252648 | ||
Comparative analysis of human ex vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary tale | Q35692415 | ||
THE PRODUCTION OF BLOOD PLATELETS IN THE LUNGS. | Q36256997 | ||
Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes | Q36313419 | ||
High-level transgene expression in induced pluripotent stem cell-derived megakaryocytes: correction of Glanzmann thrombasthenia | Q37535262 | ||
Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? | Q37671038 | ||
A future with less HLA: potential clinical applications of HLA-universal cells | Q38416517 | ||
Conversion of adult endothelium to immunocompetent haematopoietic stem cells | Q38703218 | ||
Continued decline in blood collection and transfusion in the United States-2015 | Q38738078 | ||
CRISPR/Cas9 system and its applications in human hematopoietic cells | Q38979642 | ||
Hematopoietic stem cell-independent hematopoiesis: emergence of erythroid, megakaryocyte, and myeloid potential in the mammalian embryo | Q38993404 | ||
A view of human haematopoietic development from the Petri dish | Q39017189 | ||
Distinct characteristics of neonatal platelet reactivity | Q39381339 | ||
Epigenetic reprogramming induces the expansion of cord blood stem cells | Q40064521 | ||
Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure | Q40244410 | ||
Platelet concentrates: Balancing between efficacy and safety? | Q40594144 | ||
Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo | Q41460916 | ||
Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells | Q42211301 | ||
Scalable generation of universal platelets from human induced pluripotent stem cells. | Q43010381 | ||
Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment | Q45864060 | ||
P433 | issue | 6 | |
P304 | page(s) | 565-571 | |
P577 | publication date | 2017-11-01 | |
P1433 | published in | Current Opinion in Hematology | Q15757961 |
P1476 | title | Current status of blood 'pharming': megakaryoctye transfusions as a source of platelets | |
P478 | volume | 24 |
Search more.